关注
massimo tempestilli
massimo tempestilli
在 inmi.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza
C Gioia, C Castilletti, M Tempestilli, P Piacentini, L Bordi, R Chiappini, ...
Emerging Infectious Diseases 14 (1), 121, 2008
1182008
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
M Tempestilli, P Caputi, V Avataneo, S Notari, O Forini, L Scorzolini, ...
Journal of Antimicrobial Chemotherapy 75 (10), 2977-2980, 2020
1142020
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
A Sacchi, G Grassi, V Bordoni, P Lorenzini, E Cimini, R Casetti, ...
Cell death & disease 11 (10), 921, 2020
1102020
Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level
S El Daker, A Sacchi, M Tempestilli, C Carducci, D Goletti, V Vanini, ...
PloS one 10 (4), e0123772, 2015
832015
Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells
F Poccia, C Gioia, F Martini, A Sacchi, P Piacentini, M Tempestilli, C Agrati, ...
Aids 23 (5), 555-565, 2009
672009
Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders
V Cartocci, M Catallo, M Tempestilli, M Segatto, FW Pfrieger, ...
Neuroscience 372, 27-37, 2018
532018
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women
J Ivanovic, E Nicastri, MM Anceschi, P Ascenzi, F Signore, G Pisani, ...
Current HIV Research 7 (6), 620-625, 2009
432009
UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
S Notari, M Tempestilli, G Fabbri, R Libertone, A Antinori, A Ammassari, ...
Journal of Chromatography B 1073, 183-190, 2018
372018
Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC‐UV
S Notari, C Tommasi, E Nicastri, R Bellagamba, M Tempestilli, LP Pucillo, ...
IUBMB life 61 (4), 470-475, 2009
352009
Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs
G Berno, M Zaccarelli, C Gori, M Tempestilli, A Antinori, CF Perno, ...
BMC medical genetics 15, 1-7, 2014
322014
Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery
C Agrati, C Marianecci, S Sennato, M Carafa, V Bordoni, E Cimini, ...
Nanomedicine: Nanotechnology, Biology and Medicine 7 (2), 153-161, 2011
322011
Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection
C Nisii, M Tempestilli, C Agrati, F Poccia, G Tocci, MA Longo, G D'Offizi, ...
Journal of hepatology 44 (3), 475-483, 2006
322006
Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety
J Ivanovic, R Bellagamba, E Nicastri, F Signore, C Vallone, M Tempestilli, ...
Aids 24 (7), 1083-1084, 2010
312010
Determination of antituberculosis drug concentration in human plasma by MALDI‐TOF/TOF
S Notari, C Mancone, M Sergi, F Gullotta, N Bevilacqua, M Tempestilli, ...
Iubmb Life 62 (5), 387-393, 2010
252010
Sildenafil plasma concentrations in two HIV patients with pulmonary hypertension treated with ritonavir-boosted protease inhibitors
P Chinello, S Cicalini, S Pichini, R Pacifici, M Tempestilli, N Petrosillo
Current HIV Research 10 (2), 162-164, 2012
232012
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
C Tommasi, R Bellagamba, M Tempestilli, A D'Avolio, AL Gallo, J Ivanovic, ...
Malaria journal 10, 1-3, 2011
232011
Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir
M Tempestilli, R Lionetti, G D'Offizi, M Montalbano, A Giaffreda, S Fazio, ...
Hepatology 60 (3), 1109-1110, 2014
172014
Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors
M Tempestilli, E Gentilotti, C Tommasi, E Nicastri, F Martini, P De Nardo, ...
International Immunopharmacology 16 (4), 492-497, 2013
172013
Low plasma concentrations of albumin influence the affinity column–mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver …
M Tempestilli, E Di Stasio, MR Basile, F Elisei, M Antonini, GM Ettorre, ...
Therapeutic drug monitoring 35 (1), 96-100, 2013
172013
Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients
M Tempestilli, L Pucci, S Notari, AD Caro, C Castilletti, MR Rivelli, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 53 (12), 1967-1973, 2015
162015
系统目前无法执行此操作,请稍后再试。
文章 1–20